2026-07-16T12:40:44Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/190452025-02-05T12:01:09Zcom_20.500.12105_2052com_20.500.12105_2051com_20.500.12105_15322col_20.500.12105_19609col_20.500.12105_16966col_20.500.12105_16982

00925njm 22002777a 4500 dc Redondo, Esther author Rivero-Calle, Irene author Mascarós, Enrique author Ocaña, Daniel author Jimeno, Isabel author Gil, Ángel author Linares, Manuel author Onieva-García, María Ángeles author González-Romo, Fernando author Yuste, Jose Enrique author Martinón-Torres, Federico author 2024-03 Respiratory syncytial virus (RSV) is a major cause of respiratory tract infections in adults, particularly older adults and those with underlying medical conditions. Vaccination has emerged as a potential key strategy to prevent RSV-related morbidity and mortality. This Neumoexperts Prevention (NEP) Group scientific paper aims to provide an evidence-based positioning and RSV vaccination recommendations for adult patients. We review the current literature on RSV burden and vaccine development and availability, emphasising the importance of vaccination in the adult population. According to our interpretation of the data, RSV vaccines should be part of the adult immunisation programme, and an age-based strategy should be preferred over targeting high-risk groups. The effectiveness and efficiency of this practice will depend on the duration of protection and the need for annual or more spaced doses. Our recommendations should help healthcare professionals formulate guidelines and implement effective vaccination programmes for adult patients at risk of RSV infection now that specific vaccines are available. Redondo E, Rivero-Calle I, Mascarós E, Ocaña D, Jimeno I, Gil Á, Linares M, Onieva-García MÁ, González-Romo F, Yuste J, Martinón-Torres F. Respiratory Syncytial Virus Vaccination Recommendations for Adults Aged 60 Years and Older: The NeumoExperts Prevention Group Position Paper. Arch Bronconeumol. 2024 Mar;60(3):161-170. 10.1016/j.arbres.2024.01.004 1579-2129 Archivos de bronconeumologia 38311509 http://hdl.handle.net/20.500.12105/19045 Respiratory syncytial virus RSV Adult patients Vaccination Recommendations Preventive measures High-risk populations Chronic obstructive pulmonary disease Respiratory Syncytial Virus Vaccination Recommendations for Adults Aged 60 Years and Older: The NeumoExperts Prevention Group Position Paper